-
1دورية أكاديمية
المؤلفون: Grizzi G, Ghidini M, Botticelli A, Tomasello G, Ghidini A, Grossi F, Fusco N, Cabiddu M, Savio T, Petrelli F
المصدر: Cancer Management and Research, Vol Volume 12, Pp 675-686 (2020)
مصطلحات موضوعية: neoadjuvant endocrine therapy, breast cancer, cdk 4/6 inhibitors, mtor inhibitors, pi3k inhibitors, aromatase inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.dovepress.com/strategies-for-increasing-the-effectiveness-of-aromataseTest-inhibitors-in-peer-reviewed-article-CMAR; https://doaj.org/toc/1179-1322Test
-
2دورية أكاديمية
المؤلفون: Cabahug VLO, Uy HS, Yu-Keh E, Sapno KJD
المصدر: Clinical Ophthalmology, Vol Volume 13, Pp 649-669 (2019)
مصطلحات موضوعية: Non-infectious uveitis, Immunosuppression, Corticosteroid-sparing, Sirolimus, mTOR inhibitors, uveitis treatment, Ophthalmology, RE1-994
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Yao JC, Oh DY, Qian JM, Park YS, Herbst F, Ridolfi A, Izquierdo M, Ito T, Jia LQ, Komoto I, Sriuranpong V, Shimada Y
المصدر: OncoTargets and Therapy, Vol Volume 12, Pp 1717-1728 (2019)
مصطلحات موضوعية: mTOR inhibitors, everolimus, RADIANT-4, neuroendocrine tumors, East Asian population, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E
المصدر: OncoTargets and Therapy, Vol Volume 11, Pp 1223-1228 (2018)
مصطلحات موضوعية: metastatic renal cell carcinoma, mTOR inhibitors, everolimus, observational study, real- life setting, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Lakhlili W, Yasri A, Ibrahimi A
المصدر: OncoTargets and Therapy, Vol Volume 9, Pp 7345-7353 (2016)
مصطلحات موضوعية: mTOR Inhibitors, QSAR, PLS, docking, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.dovepress.com/structurendashactivity-relationships-study-ofTest-mtor-kinase-inhibition-u-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930Test
-
6دورية أكاديمية
المؤلفون: Jerusalem, Guy, RORIVE, Andrée, COLLIGNON, Joëlle
المصدر: Breast Cancer, 6, 43-57 (2014)
مصطلحات موضوعية: biomarkers, breast cancer, everolimus, mTOR inhibitors, phosphatidylinositol-3-kinase/protein kinase B-mTOR pathway, treatment, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
العلاقة: urn:issn:1340-6868; urn:issn:1880-4233; https://orbi.uliege.be/handle/2268/175408Test; info:hdl:2268/175408; https://orbi.uliege.be/bitstream/2268/175408/1/Use%20of%20mTOR%20inhibitors%20in%20the%20treatment%20of%20breast%20cancer.pdfTest; scopus-id:2-s2.0-84901438787; info:pmid:24833916
الإتاحة: https://doi.org/10.2147/BCTT.S38679Test
https://orbi.uliege.be/handle/2268/175408Test
https://orbi.uliege.be/bitstream/2268/175408/1/Use%20of%20mTOR%20inhibitors%20in%20the%20treatment%20of%20breast%20cancer.pdfTest -
7
المؤلفون: Azeddine Ibrahimi, Wiame Lakhlili, Abdelaziz Yasri
المصدر: OncoTargets and therapy
مصطلحات موضوعية: 0301 basic medicine, Drug, 030103 biophysics, Quantitative structure–activity relationship, mTOR inhibitors, Chemistry, media_common.quotation_subject, Computational biology, PLS, Kinase inhibition, Discovery and development of mTOR inhibitors, quantitative structureactivity relationship, Chemical library, 03 medical and health sciences, chemistry.chemical_compound, Oncology, Docking (molecular), docking, partial least square, Pharmacology (medical), Homology modeling, PI3K/AKT/mTOR pathway, media_common, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d209973ef040c4c99f71d0fcead0e0eTest
http://europepmc.org/articles/PMC5144904Test -
8
المؤلفون: Rohan Shahani, Kevin Kwan, Anil Kapoor
المصدر: Drug, Healthcare and Patient Safety, Vol 2010, Iss default, Pp 85-91 (2010)
Drug, healthcare and patient safetyمصطلحات موضوعية: Oncology, medicine.medical_specialty, mTOR inhibitors, VEGF inhibitors, Review, Pharmacology, metastatic renal cell carcinoma, chemistry.chemical_compound, Renal cell carcinoma, Internal medicine, medicine, Mucositis, PI3K/AKT/mTOR pathway, Pneumonitis, lcsh:R5-920, Everolimus, business.industry, Genitourinary system, Health Policy, medicine.disease, everolimus, Temsirolimus, Vascular endothelial growth factor, chemistry, business, lcsh:Medicine (General), medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56b236aefd3e63a55a3277735ca9327Test
http://www.dovepress.com/safety-and-clinical-efficacy-of-everolimus-in-the-treatment-of-advance-a4669Test -
9
المؤلفون: Bullock, Andrea, McDermott, David F, Atkins, Michael B
المصدر: Cancer Management and Research, Vol 2010, Iss default, Pp 123-132 (2010)
Cancer management and researchمصطلحات موضوعية: renal cell carcinoma, prognostic criteria, Review, vascular endothelial growth factor (VEGF)-pathway inhibitors, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, mammalian target of rapamycin (mTOR) inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c004811bbd6db9957a5ce356889dd292Test
http://www.dovepress.com/management-of-metastatic-renal-cell-carcinoma-in-patients-with-poor-pr-a4485Test